Michael Gelband’s Phibro Animal Health PAHC Stock Holding History

Michael Gelband’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,157	Closed	-$1.87M	–	1960
2025 Q4	$1.87M	Buy	50,157 +33,385	+199%	+$1.36M	0.01%	795
2025 Q3	$679K	Sell	16,772 -663,611	-98%	-$21.9M	0.01%	1090
2025 Q2	$17.4M	Buy	+680,383	New	+$14.8M	0.15%	133
2024 Q4	–	Sell	-20,800	Closed	-$468K	–	1913
2024 Q3	$468K	Buy	+20,800	New	+$402K	﹤0.01%	1209
2023 Q3	–	Sell	-13,418	Closed	-$184K	–	2021
2023 Q2	$184K	Buy	+13,418	New	+$192K	﹤0.01%	1691
2022 Q4	–	Sell	-25,023	Closed	-$333K	–	2001
2022 Q3	$333K	Buy	+25,023	New	+$432K	﹤0.01%	1497
2021 Q3	–	Sell	-19,891	Closed	-$574K	–	2499
2021 Q2	$574K	Buy	+19,891	New	+$538K	0.01%	1293
2020 Q4	–	Sell	-47,419	Closed	-$825K	–	2282
2020 Q3	$825K	Buy	+47,419	New	+$1.01M	0.02%	770

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Michael Gelband's PAHC Position: Q1 2026 in Review

Michael Gelband sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 50,157 shares — an estimated $1.87M sold.

Michael Gelband first reported a position in PAHC in Q3 2020 and held it in 8 quarters. The position peaked at $17.4M in Q2 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

Michael Gelband reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
Michael Gelband sold 50,157 Phibro Animal Health shares in Q1 2026, an estimated $1.87M.
Michael Gelband first reported a position in Phibro Animal Health in Q3 2020 and held it in 8 quarters.
Michael Gelband's Phibro Animal Health position peaked at $17.4M in Q2 2025.
257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.